Enterprise

Teneobio

Private Company

TeneoBio, Inc. is developing a new class of biologics, Human Heavy Chain Antibodies (UniAbs™), as therapeutics against cancer, autoimmunity, and infectious diseases.

teneobio.com

Services/Other

U.S.

Leaders
Roland Buelow, Ph.D.

CEO

Lightspeed Team

TeneoBio, Inc. is developing a new class of biologics, Human Heavy Chain Antibodies (UniAbs™), as therapeutics against cancer, autoimmunity, and infectious diseases.